ReviewThe Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology2026
The impact of left ventricular assist devices on kidney function: a systematic review and meta-analysis.
Review in The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundKidney dysfunction is common in patients with advanced heart failure and is associated with adverse clinical outcomes. Left ventricular assist device (LVAD) implantation may influence renal function through hemodynamic and cardiorenal changes. We performed a meta-analysis to evaluate longitudinal changes in estimated glomerular filtration rate (eGFR) following LVAD implantation.
resultsWe systematically searched six databases for studies reporting eGFR before and after LVAD implantation until March 2026. The primary analysis used a multivariate random-effects meta-analysis to jointly pool repeated follow-up estimates while accounting for within-study dependence across time points. Pooled mean changes in eGFR and 95% confidence intervals (CIs) were estimated at 1 week, 2 weeks, 1 month, 3 months, 6 months, 9 months, 1 year, 2 years, and 3 years after implantation. A total of 38 studies contributing 95 effect sizes were included. Compared with baseline, pooled mean eGFR was significantly higher at 1 week (18.83 mL/min/1.73 m²; 95% CI: 13.21, 24.46), 2 weeks (18.29; 95% CI: 12.11, 24.48), 1 month (23.77; 95% CI, 19.48, 28.07), 3 months (15.20; 95% CI: 10.95, 19.46), 6 months (7.97; 95% CI: 3.72, 12.22), 9 months (8.27; 95% CI: 2.10, 14.44), and 1 year (7.34; 95% CI: 2.83, 11.85), but not at 2 or 3 years. In subgroup analyses, studies with baseline eGFR < 60 mL/min/1.73 m² showed significant increases across all evaluated follow-up intervals, whereas those with baseline eGFR ≥ 60 mL/min/1.73 m² showed significant increases only through 3 months.
conclusionsLVAD implantation was associated with higher eGFR during the early postoperative period, with the largest increase observed at 1 month. However, because most included studies were pre-post analyses without non-LVAD comparator groups, these findings should be interpreted cautiously and do not establish a causal effect. Future research should explore the long-term impact of LVAD on renal health to optimize care strategies and outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.